Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
1.560
-0.060 (-3.70%)
At close: Sep 8, 2026, 4:00 PM EDT
1.520
-0.100 (-6.17%)
After-hours: Sep 8, 2026, 7:48 PM EDT
Nyxoah Employees
Nyxoah had 154 employees as of December 31, 2025. The number of employees decreased by 30 or -16.29% compared to the previous year.
Employees
154
Change (1Y)
-30
Growth (1Y)
-16.29%
Revenue / Employee
$161,023
Profits / Employee
-$713,606
Market Cap
164.58M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 154 | -30 | -16.29% |
| Dec 31, 2024 | 184 | 37 | 25.07% |
| Dec 31, 2023 | 147 | 9 | 6.76% |
| Dec 31, 2022 | 138 | 32 | 29.96% |
| Dec 31, 2021 | 106 | 34 | 47.15% |
| Mar 31, 2021 | 79 | 36 | 84.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| Neuronetics | 658 |
| InfuSystem Holdings | 473 |
| Quanterix | 450 |
| Apyx Medical | 205 |
| Electromed | 197 |
| Profound Medical | 162 |
| Quantum-Si incorporated | 145 |
NYXH News
- 1 day ago - Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System - GlobeNewsWire
- 6 days ago - Nyxoah announces ACCESS study meets primary safety, efficacy endpoints - TheFly
- 22 days ago - Nyxoah price target lowered to $6 from $11 at Cantor Fitzgerald - TheFly
- 4 weeks ago - Nyxoah price target lowered to $2.31 from $2.86 at Baird - TheFly
- 4 weeks ago - Nyxoah price target lowered to $6 from $7 at Piper Sandler - TheFly
- 4 weeks ago - Nyxoah price target lowered to $4 from $13 at Oppenheimer - TheFly
- 4 weeks ago - Nyxoah Q2 Earnings Call Highlights - MarketBeat
- 4 weeks ago - Nyxoah Earnings Call Transcript: Q2 2026 - Transcripts